Icon plc diskutieren
Icon plc
WKN: 932242 / Symbol: ICLR / Name: ICON / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
155,35 €
1,74 %
ICON Public Limited (NASDAQ: ICLR) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $263.00 price target on the stock.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $263.00 price target on the stock.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at JPMorgan Chase & Co. from $280.00 to $265.00. They now have an "overweight" rating on the stock.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Truist Financial Co. from $284.00 to $262.00. They now have a "buy" rating on the stock.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Barclays PLC from $275.00 to $240.00. They now have an "overweight" rating on the stock.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Citigroup Inc. from $290.00 to $215.00. They now have a "buy" rating on the stock.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Mizuho from $238.00 to $200.00. They now have an "outperform" rating on the stock.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Mizuho from $200.00 to $173.00. They now have an "outperform" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) had its price target raised by analysts at Evercore ISI from $155.00 to $170.00. They now have an "outperform" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $224.00 price target on the stock, up previously from $150.00.
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) had its price target raised by analysts at Evercore ISI from $170.00 to $240.00. They now have an "outperform" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) had its price target raised by analysts at Truist Financial Corporation from $187.00 to $234.00. They now have a "buy" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) had its price target raised by analysts at UBS Group AG from $170.00 to $240.00. They now have a "buy" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) had its price target raised by analysts at Mizuho from $173.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Baird R W from a "hold" rating to a "strong-buy" rating.
Ratings data for ICLR provided by MarketBeat
Icon (NASDAQ:ICLR) had its price target raised by analysts at Robert W. Baird from $222.00 to $224.00. They now have an "outperform" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Icon (NASDAQ:ICLR) was upgraded by analysts at Rothschild & Co Redburn from a "neutral" rating to a "buy" rating. They now have a $236.00 price target on the stock.
Ratings data for ICLR provided by MarketBeat
Neueste Beiträge
Jefferies_Financial_ in M&T Bank Corp. diskutieren